Methadone and the Heart: What the Clinician Needs to Know

Author(s): Sanju George, Karen Moreira, Mosun Fapohunda

Journal Name: Current Drug Abuse Reviews
Continued as Current Drug Research Reviews

Volume 1 , Issue 3 , 2008


Evidence has emerged in recent years on methadones cardiac arrhythogenic potential – i.e. QT prolongation and Torsades de Pointes (TdP). Given the potentially fatal consequences of these adverse effects, clinicians need to be alert to avoid this going unrecognised and untreated. In this paper, we briefly discuss normal cardiac conduction and electrocardiogram (ECG) waveforms, and look at theories of methadone – induced QT prolongation and TdP. We then present a summary of the existing evidence base for methadone – associated TdP and offer guidance for the clinician on the need for cardiac screening of patients on methadone treatment.

Keywords: Electrocardiogram, guidelines, heart, methadone, QT prolongation, risk, Torsades de Pointes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [297 - 302]
Pages: 6
DOI: 10.2174/1874473710801030297
Price: $58

Article Metrics

PDF: 13